MANDOL ADD-VANTAGE: CEFAMANDOLE NAFATE FOR INJECTION.
CEFAMANDOLE NAFATE FOR INJECTION. Key specifications include physical_form: POWDER, primary_container_type: VIAL, SINGLE DOSE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 25, primary_container_content_quantity: 1.000 GRAMS OF ACTIVE INGREDIENT G, active_medicament_medicinal_strength: 1.000 GRAMS CEFAMANDOLE EQUIVALENT G. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-308-9436, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | POWDER |
| primary_container_type | VIAL, SINGLE DOSE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 25 |
| primary_container_content_quantity | 1.000 GRAMS OF ACTIVE INGREDIENT G |
| active_medicament_medicinal_strength | 1.000 GRAMS CEFAMANDOLE EQUIVALENT G |
| part_name_assigned_by_controlling_agency | CEFAMANDOLE NAFATE FOR INJECTION USP 1GM VIAL 25S |
| NSN | 6505-01-308-9436 |
| PRIMARY CONTAINER CONTENT QUANTITY | 1.000 GRAMS OF ACTIVE INGREDIENT G |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
| PHYSICAL FORM | POWDER |
| SPECIAL FEATURES | 18 ML CAPACITY GLASS VIAL WITH DOUBLED LEAD SCREW THREAD TO INTERLOCK WITH INLET PORT OF DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,6505-01-260-1239 AND SODIUM CHLORIDE INJECTION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715; EACH DRUG VIAL SHALL BE ENCLOSED IN AN UPPER AND LOWER PLASTIC SHROUD |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFAMANDOLE NAFATE FOR INJECTION USP 1GM VIAL 25S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1.000 GRAMS CEFAMANDOLE EQUIVALENT G |
| TOTAL PRIMARY CONTAINER QUANTITY | 25 |
No substitute or cross-reference records for this part.